3 Shops Await Word on Novartis' Elidel

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Three agencies are awaiting a decision in the review for creative duties on Novartis’ Elidel account, sources said.

The East Hanover, N.J., client in September heard pitches from the incumbent, WPP Group’s Quantum Group in Parsippany, N.J.; and Omnicom Group’s Merkley Newman Harty & Partners and Interpublic Group’s Deutsch, both New York, sources said. A decision is expected in two weeks.

Quantum launched the first ad campaign for the prescription skin cream to treat eczema in March.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in